NTLA Intellia Therapeutics, Inc.
Nasdaq · SEC CIK 1652130 · EDGAR
- Bought, last 12 months
- $1.40M 1 purchases by 1 insiders
- Sold, last 12 months
- $2.17M 16 sales by 7 insiders
- Filings on record
- 160 since 2021-07-06, latest 2026-08-24 16:05
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| LEONARD JOHN M | Pres, CEO, Dir | — | $1.44M |
| Cohen Fred E | Dir | $1.40M | — |
| Dulac Edward J III | EVP, CFO | — | $234.2K |
| BASTA JAMES | EVP, GC | — | $112.4K |
| Lebwohl David | EVP, Chief Medical Off | — | $109.6K |
| Dube Michael P | VP, CAO | — | $104.4K |
| Clark Eliana | EVP, Chief Technical Off | — | $96.0K |
| Schultes Birgit C | EVP, CSO | — | $78.9K |
| Bhanji Muna | Dir | — | — |
| Keresty Georgia | Dir | — | — |
Transactions 187
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-07-10 | 2023-07-06 | NTLA | Bhanji Muna | Dir | S - Sale | $39.30 | -1,867 | 12.5K | -13% | -$73.4K | |
| 2023-07-06 | 2023-07-03 | NTLA | Clark Eliana | EVP, Chief Technical Off | S - Sale | $40.51 | -360 | 45.1K | -0.8% | -$14.6K | |
| D | 2023-06-22 | 2023-06-20 | NTLA | Clark Eliana | EVP, Chief Technical Off | M - OptEx | $12.27 | +5,000 | 50.1K | +11% | +$61.4K |
| D | 2023-06-22 | 2023-06-20 | NTLA | Clark Eliana | EVP, Chief Technical Off | S - Sale+OE | $45.00 | -5,000 | 45.1K | -10% | -$225.0K |
| D | 2023-06-16 | 2023-06-14 | NTLA | Keresty Georgia | Dir | A - Grant | $0.00 | +4,425 | 16.1K | +38% | $0 |
| D | 2023-06-16 | 2023-06-14 | NTLA | GOODMAN JESSE | Dir | A - Grant | $0.00 | +4,425 | 11.7K | +61% | $0 |
| D | 2023-06-16 | 2023-06-14 | NTLA | Cohen Fred E | Dir | A - Grant | $0.00 | +4,425 | 41.7K | +12% | $0 |
| D | 2023-06-16 | 2023-06-14 | NTLA | Crowley John F | Dir | A - Grant | $0.00 | +4,425 | 11.7K | +61% | $0 |
| D | 2023-06-16 | 2023-06-14 | NTLA | Verwiel Frank | Dir | A - Grant | $0.00 | +4,425 | 11.7K | +61% | $0 |
| D | 2023-06-16 | 2023-06-14 | NTLA | Bhanji Muna | Dir | A - Grant | $0.00 | +4,425 | 14.4K | +44% | $0 |
| D | 2023-06-16 | 2023-06-14 | NTLA | CHASE WILLIAM J | Dir | A - Grant | $0.00 | +1,673 | 19.0K | +10% | $0 |
| D | 2023-04-18 | 2023-04-14 | NTLA | CHASE WILLIAM J | Dir | A - Grant | $0.00 | +10.5K | 17.3K | +154% | $0 |
| DM | 2023-03-03 | 2023-03-01 | NTLA | BASTA JAMES | EVP, GC | A - Grant | $0.00 | +36.8K | 44.1K | +505% | $0 |
| D | 2023-03-03 | 2023-03-02 | NTLA | BASTA JAMES | EVP, GC | S - Sale | $43.88 | -1,088 | 55.3K | -2% | -$47.7K |
| D | 2023-03-03 | 2023-03-01 | NTLA | Lebwohl David | EVP, Chief Medical Off | A - Grant | $0.00 | +30.7K | 56.4K | +119% | $0 |
| D | 2023-03-03 | 2023-03-01 | NTLA | Sepp-Lorenzino Laura | EVP, CSO | A - Grant | $0.00 | +29.9K | 47.6K | +170% | $0 |
| D | 2023-03-03 | 2023-03-01 | NTLA | Goddard Glenn | EVP, CFO | A - Grant | $0.00 | +27.5K | 42.9K | +178% | $0 |
| DM | 2023-03-03 | 2023-03-01 | NTLA | Clark Eliana | EVP, Chief Technical Off | A - Grant | $0.00 | +30.7K | 39.0K | +368% | $0 |
| D | 2023-03-03 | 2023-03-01 | NTLA | Hicks Derek | EVP, Chief Business Off | A - Grant | $0.00 | +23.6K | 40.9K | +136% | $0 |
| D | 2023-03-03 | 2023-03-01 | NTLA | LEONARD JOHN M | Pres, CEO, Dir | A - Grant | $0.00 | +91.0K | 857.9K | +12% | $0 |
| 2023-01-06 | 2023-01-04 | NTLA | BASTA JAMES | EVP, GC | S - Sale | $37.21 | -1,138 | 19.6K | -5% | -$42.3K | |
| M | 2023-01-06 | 2023-01-04+ | NTLA | Sepp-Lorenzino Laura | EVP, CSO | S - Sale | $37.82 | -4,838 | 17.6K | -22% | -$183.0K |
| 2023-01-06 | 2023-01-04 | NTLA | LEONARD JOHN M | Pres, CEO, Dir | S - Sale | $37.21 | -6,673 | 766.8K | -0.9% | -$248.3K | |
| 2023-01-06 | 2023-01-04 | NTLA | Lebwohl David | EVP, Chief Medical Off | S - Sale | $37.21 | -2,574 | 25.7K | -9% | -$95.8K | |
| 2023-01-06 | 2023-01-04 | NTLA | Goddard Glenn | EVP, CFO | S - Sale | $37.21 | -2,427 | 15.4K | -14% | -$90.3K | |
| M | 2023-01-06 | 2022-07-01+ | NTLA | Clark Eliana | EVP, Chief Technical Off | S - Sale | $37.65 | -2,028 | 16.2K | -11% | -$76.4K |
| 2023-01-06 | 2023-01-04 | NTLA | Hicks Derek | EVP, Chief Business Off | S - Sale | $37.21 | -1,812 | 17.3K | -9% | -$67.4K | |
| D | 2023-01-04 | 2023-01-01 | NTLA | Lebwohl David | EVP, Chief Medical Off | M - OptEx | — | +3,187 | 28.3K | +13% | — |
| D | 2023-01-04 | 2023-01-01 | NTLA | LEONARD JOHN M | Pres, CEO, Dir | M - OptEx | — | +7,848 | 773.5K | +1% | — |
| D | 2023-01-04 | 2023-01-01 | NTLA | Sepp-Lorenzino Laura | EVP, CSO | M - OptEx | — | +3,500 | 22.5K | +18% | — |
| D | 2023-01-04 | 2023-01-01 | NTLA | Goddard Glenn | EVP, CFO | M - OptEx | — | +3,062 | 17.8K | +21% | — |
| D | 2022-06-16 | 2022-06-14 | NTLA | Verwiel Frank | Dir | A - Grant | $0.00 | +5,197 | 7,291 | +248% | $0 |
| D | 2022-06-16 | 2022-06-14 | NTLA | Keresty Georgia | Dir | A - Grant | $0.00 | +5,197 | 11.7K | +80% | $0 |
| D | 2022-06-16 | 2022-06-14 | NTLA | GOODMAN JESSE | Dir | A - Grant | $0.00 | +5,197 | 7,291 | +248% | $0 |
| D | 2022-06-16 | 2022-06-14 | NTLA | FORMELA JEAN FRANCOIS | Dir | A - Grant | $0.00 | +5,197 | 7,291 | +248% | $0 |
| D | 2022-06-16 | 2022-06-14 | NTLA | Cohen Fred E | Dir | A - Grant | $0.00 | +5,197 | 37.3K | +16% | $0 |
| D | 2022-06-16 | 2022-06-14 | NTLA | Crowley John F | Dir | A - Grant | $0.00 | +5,197 | 7,291 | +248% | $0 |
| D | 2022-06-16 | 2022-06-14 | NTLA | Bhanji Muna | Dir | A - Grant | $0.00 | +2,014 | 9,968 | +25% | $0 |
| D | 2022-06-16 | 2022-06-14 | NTLA | DORSA CAROLINE | Dir | A - Grant | $0.00 | +5,197 | 12.7K | +69% | $0 |
| D | 2022-05-02 | 2022-04-28 | NTLA | Bhanji Muna | Dir | A - Grant | $0.00 | +7,954 | 7,954 | New | $0 |
| DA | 2022-04-14 | 2021-06-23 | NTLA | Keresty Georgia | Dir | A - Grant | $0.00 | +1,569 | 6,524 | +32% | $0 |
| D | 2022-03-07 | 2022-03-01 | NTLA | Clark Eliana | EVP, Chief Technical Off | A - Grant | $0.00 | +10.5K | 16.2K | +187% | $0 |
| D | 2022-03-04 | 2022-01-01 | NTLA | LEONARD JOHN M | Pres, CEO, Dir | M - OptEx | — | +7,848 | 727.2K | +1% | — |
| D | 2022-03-04 | 2022-03-01 | NTLA | LEONARD JOHN M | Pres, CEO, Dir | A - Grant | $0.00 | +41.0K | 765.6K | +6% | $0 |
| D | 2022-03-04 | 2022-01-01 | NTLA | LEONARD JOHN M | Pres, CEO, Dir | S - Sale+OE | $112.26 | -2,493 | 724.7K | -0.3% | -$279.9K |
| D | 2022-03-03 | 2022-03-01 | NTLA | Lebwohl David | EVP, Chief Medical Off | A - Grant | $0.00 | +13.8K | 24.7K | +126% | $0 |
| D | 2022-03-03 | 2022-01-01 | NTLA | Lebwohl David | EVP, Chief Medical Off | S - Sale+OE | $112.24 | -1,051 | 10.9K | -9% | -$118.0K |
| D | 2022-03-03 | 2022-01-01 | NTLA | Lebwohl David | EVP, Chief Medical Off | M - OptEx | — | +3,187 | 12.0K | +36% | — |
| D | 2022-03-03 | 2022-01-01 | NTLA | Goddard Glenn | EVP, CFO | S - Sale+OE | $112.24 | -1,013 | 2,049 | -33% | -$113.7K |
| D | 2022-03-03 | 2022-01-01 | NTLA | Goddard Glenn | EVP, CFO | M - OptEx | — | +3,062 | 3,062 | New | — |
| D | 2022-03-03 | 2022-03-01 | NTLA | Goddard Glenn | EVP, CFO | A - Grant | $0.00 | +12.7K | 14.8K | +621% | $0 |
| DM | 2022-03-03 | 2022-03-01 | NTLA | BASTA JAMES | EVP, GC | A - Grant | $0.00 | +20.7K | 20.7K | New | $0 |
| D | 2022-03-03 | 2022-03-01 | NTLA | Sepp-Lorenzino Laura | EVP, CSO | A - Grant | $0.00 | +13.8K | 18.6K | +287% | $0 |
| D | 2022-03-03 | 2022-01-01 | NTLA | Sepp-Lorenzino Laura | EVP, CSO | S - Sale+OE | $112.25 | -1,148 | 4,815 | -19% | -$128.9K |
| D | 2022-03-03 | 2022-01-01 | NTLA | Sepp-Lorenzino Laura | EVP, CSO | M - OptEx | — | +3,500 | 5,963 | +142% | — |
| D | 2022-01-05 | 2022-01-03 | NTLA | Hicks Derek | EVP, Chief Business Off | A - Grant | $0.00 | +19.1K | 19.1K | New | $0 |
| DM | 2021-11-09 | 2021-11-05 | NTLA | Lebwohl David | EVP, Chief Medical Off | S - Sale+OE | $132.72 | -2,400 | 9,914 | -19% | -$318.5K |
| D | 2021-11-09 | 2021-11-05 | NTLA | Lebwohl David | EVP, Chief Medical Off | M - OptEx | $12.62 | +2,400 | 11.1K | +28% | +$30.3K |
| DM | 2021-10-15 | 2021-10-14 | NTLA | Lebwohl David | EVP, Chief Medical Off | S - Sale+OE | $128.44 | -2,400 | 9,714 | -20% | -$308.2K |
| D | 2021-10-15 | 2021-10-14 | NTLA | Lebwohl David | EVP, Chief Medical Off | M - OptEx | $12.62 | +2,400 | 11.1K | +28% | +$30.3K |
| D | 2021-10-13 | 2021-10-11 | NTLA | Crowley John F | Dir | S - Sale+OE | $119.55 | -2,500 | 2,094 | -54% | -$298.9K |
| D | 2021-10-13 | 2021-10-11 | NTLA | Crowley John F | Dir | M - OptEx | $18.83 | +2,500 | 4,594 | +119% | +$47.1K |
| DM | 2021-10-07 | 2021-10-05 | NTLA | Crowley John F | Dir | S - Sale+OE | $130.54 | -10.0K | 10.8K | -48% | -$1.31M |
| D | 2021-10-07 | 2021-10-05 | NTLA | Crowley John F | Dir | M - OptEx | $18.83 | +10.0K | 12.1K | +478% | +$188.3K |
| D | 2021-09-27 | 2021-09-24 | NTLA | Lebwohl David | EVP, Chief Medical Off | M - OptEx | $12.62 | +7,923 | 8,714 | +1,002% | +$100.0K |
| D | 2021-09-23 | 2021-09-21 | NTLA | Lebwohl David | EVP, Chief Medical Off | S - Sale+OE | $149.81 | -2,400 | 791 | -75% | -$359.5K |
| D | 2021-09-23 | 2021-09-21 | NTLA | Lebwohl David | EVP, Chief Medical Off | M - OptEx | $12.62 | +2,400 | 3,191 | +303% | +$30.3K |
| D | 2021-09-09 | 2021-09-07 | NTLA | Goddard Glenn | EVP, CFO | M - OptEx | $14.58 | +3,482 | 3,482 | New | +$50.8K |
| D | 2021-09-09 | 2021-09-07 | NTLA | Goddard Glenn | EVP, CFO | S - Sale+OE | $180.12 | -3,482 | 0 | -100% | -$627.2K |
| DM | 2021-09-01 | 2021-08-30 | NTLA | Sepp-Lorenzino Laura | EVP, CSO | M - OptEx | $14.01 | +97.0K | 99.4K | +4,057% | +$1.36M |
| DM | 2021-09-01 | 2021-08-30 | NTLA | Sepp-Lorenzino Laura | EVP, CSO | S - Sale+OE | $154.83 | -97.0K | 6,766 | -93% | -$15.02M |
| DM | 2021-09-01 | 2021-08-30+ | NTLA | LEONARD JOHN M | Pres, CEO, Dir | M - OptEx | $17.06 | +121.4K | 758.1K | +19% | +$2.07M |
| DM | 2021-09-01 | 2021-08-30+ | NTLA | LEONARD JOHN M | Pres, CEO, Dir | S - Sale+OE | $160.83 | -121.4K | 719.3K | -14% | -$19.52M |
| DM | 2021-09-01 | 2021-08-30+ | NTLA | Goddard Glenn | EVP, CFO | M - OptEx | $18.99 | +30.0K | 24.8K | New | +$569.6K |
| DM | 2021-09-01 | 2021-08-30+ | NTLA | Goddard Glenn | EVP, CFO | S - Sale+OE | $159.45 | -30.0K | 900 | -97% | -$4.78M |
| D | 2021-09-01 | 2021-08-30 | NTLA | Lebwohl David | EVP, Chief Medical Off | M - OptEx | $12.62 | +2,400 | 3,191 | +303% | +$30.3K |
| DM | 2021-09-01 | 2021-08-30 | NTLA | Lebwohl David | EVP, Chief Medical Off | S - Sale+OE | $158.04 | -2,400 | 2,291 | -51% | -$379.3K |
| DM | 2021-08-25 | 2021-08-23 | NTLA | LEONARD JOHN M | Pres, CEO, Dir | S - Sale+OE | $152.01 | -27.1K | 727.6K | -4% | -$4.13M |
| D | 2021-08-25 | 2021-08-23 | NTLA | LEONARD JOHN M | Pres, CEO, Dir | M - OptEx | $13.40 | +27.1K | 746.4K | +4% | +$363.7K |
| DM | 2021-08-20 | 2021-08-19 | NTLA | LEONARD JOHN M | Pres, CEO, Dir | S - Sale+OE | $151.28 | -22.7K | 719.3K | -3% | -$3.43M |
| D | 2021-08-20 | 2021-08-19 | NTLA | LEONARD JOHN M | Pres, CEO, Dir | M - OptEx | $13.40 | +22.7K | 742.0K | +3% | +$303.9K |
| D | 2021-08-11 | 2021-08-09 | NTLA | Lebwohl David | EVP, Chief Medical Off | M - OptEx | $12.62 | +2,400 | 3,191 | +303% | +$30.3K |
| D | 2021-08-11 | 2021-08-09 | NTLA | Lebwohl David | EVP, Chief Medical Off | S - Sale+OE | $164.05 | -2,400 | 791 | -75% | -$393.7K |
| DM | 2021-08-06 | 2021-08-05 | NTLA | Goddard Glenn | EVP, CFO | S - Sale+OE | $151.05 | -20.0K | 0 | -100% | -$3.02M |
| D | 2021-08-06 | 2021-08-05 | NTLA | Goddard Glenn | EVP, CFO | M - OptEx | $19.27 | +20.0K | 20.0K | New | +$385.4K |
| DM | 2021-08-06 | 2021-08-04 | NTLA | Sepp-Lorenzino Laura | EVP, CSO | S - Sale+OE | $138.24 | -26.0K | 20.1K | -56% | -$3.59M |
| D | 2021-08-06 | 2021-08-04 | NTLA | Sepp-Lorenzino Laura | EVP, CSO | M - OptEx | $13.40 | +26.0K | 28.4K | +1,087% | +$348.4K |
Purchase Sale Sale after option exercise All abbreviations